These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2000113)

  • 21. Secondary surfactant deficiency in neonates.
    Bissinger R; Carlson C; Hulsey T; Eicher D
    J Perinatol; 2004 Oct; 24(10):663-6. PubMed ID: 15229621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American Academy of Pediatrics Committee on Fetus and Newborn: Surfactant replacement therapy for respiratory distress syndrome.
    Pediatrics; 1991 Jun; 87(6):946-7. PubMed ID: 2034505
    [No Abstract]   [Full Text] [Related]  

  • 23. The 5 W's of surfactant for respiratory distress syndrome of the premature infant.
    Parmigiani S
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():25-7. PubMed ID: 15590430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses.
    Galan HL; Kuehl TJ
    Obstet Gynecol; 1992 Oct; 80(4):604-8. PubMed ID: 1407880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surfactant for premature infants with respiratory distress.
    Med Lett Drugs Ther; 1990 Jan; 32(809):2-3. PubMed ID: 2294387
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation.
    Kendig JW; Notter RH; Cox C; Reubens LJ; Davis JM; Maniscalco WM; Sinkin RA; Bartoletti A; Dweck HS; Horgan MJ
    N Engl J Med; 1991 Mar; 324(13):865-71. PubMed ID: 2000109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial.
    Enhorning G; Shennan A; Possmayer F; Dunn M; Chen CP; Milligan J
    Pediatrics; 1985 Aug; 76(2):145-53. PubMed ID: 3895150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasopharyngeal surfactant administration to prevent neonatal respiratory distress syndrome.
    Fernandes CJ; Horst DA; O'Donovan DJ
    J Perinatol; 2005 May; 25(5):361-2; author reply 363. PubMed ID: 15861205
    [No Abstract]   [Full Text] [Related]  

  • 30. Symposium on synthetic surfactant II: health and developmental outcomes at one year.
    J Pediatr; 1995 May; 126(5 Pt 2):S1-102. PubMed ID: 7745504
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prophylaxis and treatment of respiratory distress syndrome with different surfactants].
    Navas Serrano VM; Cuevas García MA; Vila Alvarez JA; Martínez Fernández V; Morcillo Sopena F; Valls I Soler A
    An Esp Pediatr; 2002 Jan; 56(1):40-4. PubMed ID: 11792243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surfactant replacement therapy in neonatal respiratory distress syndrome: prophylactic therapy versus treating of established disease].
    Lubetzky R; Dolberg S
    Harefuah; 1999 Nov; 137(10):464-7. PubMed ID: 10959346
    [No Abstract]   [Full Text] [Related]  

  • 33. Surfactant suspension being tested in premature neonates.
    Wilson J
    Can Med Assoc J; 1983 Jun; 128(11):1275. PubMed ID: 6687829
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective surfactant prophylaxis in preterm infants born at < or =31 weeks' gestation using the stable microbubble test in gastric aspirates.
    Fiori HH; Fritscher CC; Fiori RM
    J Perinat Med; 2006; 34(1):66-70. PubMed ID: 16489887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More and earlier surfactant for preterm infants.
    Hughes JL; McCall E; Alderdice F; Jenkins J;
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F125-6. PubMed ID: 16492949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous surfactant therapy to prevent respiratory distress syndrome.
    Lawson EE
    J Pediatr; 1987 Mar; 110(3):492-3. PubMed ID: 3643996
    [No Abstract]   [Full Text] [Related]  

  • 40. A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome.
    Gortner L; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL
    Lung; 1990; 168 Suppl():864-9. PubMed ID: 2117205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.